Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Patient Educ Couns ; 101(12): 2202-2208, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30126680

RESUMEN

OBJECTIVES: Current cardiovascular disease (CVD) nutrition guidelines do not take into account Chinese medicine (CM) principles. We created a heart healthy integrative nutritional counseling (H2INC) curriculum consistent with CM principles and current nutrition guidelines. METHODS: We conducted three phases of semi-structured interviews with key stakeholders (CM and biomedical providers and Chinese American (CAs) patients with CVD) followed by iterative development of H2INC. First, we interviewed licensed CM providers (n = 9) and laypeople with CM foods expertise (n = 1). Second, we interviewed biomedical providers (n = 11) and licensed CM providers (n = 3). Third, we conducted four focus groups with CAs (n = 20) with CVD. RESULTS: Stakeholders emphasized different principles for creating H2INC. Phase one emphasized alignment of CM diagnoses to biomedical CVD conditions. Phase two overlaid CM concepts like the nature of foods and constitution (hot/neutral/cool) with heart healthy nutrition recommendations such as MyPlate, and avoiding excess salt, fat, and sugars. Phase three demonstrated patient acceptability. CONCLUSION: By integrating CM foods principles with biomedical nutrition, this integrative approach yields culturally relevant health education for an underserved population. PRACTICE IMPLICATIONS: Integrative nutritional counseling shows promise for CAs and could support biomedical providers with little knowledge about patients' use of CM for CVD.


Asunto(s)
Asiático , Consejo , Educación en Salud/métodos , Medicina Tradicional China , Política Nutricional , Educación del Paciente como Asunto/métodos , Curriculum , Femenino , Humanos , Medicina Integrativa , Entrevistas como Asunto , Masculino , Investigación Cualitativa
2.
World J Gastroenterol ; 24(18): 2036-2046, 2018 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-29760546

RESUMEN

AIM: To determine the distribution of anthropometric parameter (AP)-z-scores and characterize associations between medications/serum biomarkers and AP-z-scores in pediatric Crohn's disease (CD). METHODS: CD patients [< chronological age (CA) 21 years] were enrolled in a cross-sectional study. Descriptive statistics were generated for participants' demographic characteristics and key variables of interest. Paired t-tests were used to compare AP-z-scores calculated based on CA (CA z-scores) and bone age (BA) (BA z-scores) for interpretation of AP's. Linear regression was utilized to examine associations between medications and serum biomarkers with AP-z-scores calculated based on CA (n = 82) and BA (n = 49). We reported regression coefficients as well as their corresponding p-values and 95% confidence intervals. RESULTS: Mean CA at the time of the study visit was 15.3 ± 3.5 (SD; range = 4.8-20.7) years. Mean triceps skinfold (P = 0.039), subscapular skinfold (P = 0.002) and mid-arm circumference (MAC) (P = 0.001) BA z-scores were higher than corresponding CA z-scores. Medications were positively associated with subscapular skinfold [adalimumab (P = 0.018) and methotrexate (P = 0.027)] and BMI CA z-scores [adalimumab (P = 0.029)]. Azathioprine/6-mercaptopurine were negatively associated with MAC (P = 0.045), subscapular skinfold (P = 0.014), weight (P = 0.002) and BMI (P = 0.013) CA z-scores. ESR, CRP, and WBC count were negatively associated, while albumin and IGF-1 BA z-scores were positively associated, with specific AP z-scores (P < 0.05). Mean height CA z-scores were higher in females, not males, treated with infliximab (P = 0.038). Hemoglobin (P = 0.018) was positively associated, while platelets (P = 0.005), ESR (P = 0.003) and CRP (P = 0.039) were negatively associated with height CA z-scores in males, not females. CONCLUSION: Our results suggest poor efficacy of thiopurines and a possible sex difference in statural growth response to infliximab in pediatric CD. Prospective longitudinal studies are required.


Asunto(s)
Antropometría , Azatioprina/uso terapéutico , Enfermedad de Crohn/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Infliximab/uso terapéutico , Mercaptopurina/uso terapéutico , Adolescente , Adulto , Azatioprina/farmacología , Biomarcadores/sangre , Composición Corporal/efectos de los fármacos , Desarrollo Óseo , Niño , Preescolar , Enfermedad de Crohn/sangre , Enfermedad de Crohn/complicaciones , Estudios Transversales , Femenino , Humanos , Inmunosupresores/farmacología , Infliximab/farmacología , Masculino , Mercaptopurina/farmacología , Estado Nutricional/efectos de los fármacos , Estudios Prospectivos , Factores Sexuales , Resultado del Tratamiento , Adulto Joven
3.
Prev Med Rep ; 8: 1-5, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28856083

RESUMEN

Consumption of non- or low-fat dairy products is recommended as a strategy to lower the risk of childhood obesity. However, recent evidence suggests that consumption of whole fat dairy products may, in fact, be protective against obesity. Our objective was to determine the association between milk fat consumption and severe obesity among three-year-old Latino children, a population with a disproportionate burden of obesity and severe obesity. 24-hour-dietary recalls were conducted to determine child intake in San Francisco based cohort recruited in 2006-7. Mother-child dyads were weighed and measured. The 24-hour recall data was analyzed to determine participants' consumption of whole milk, 2% milk, and 1% milk. The milk consumption data was used to calculate grams of milk fat consumed. The cross-sectional association between milk fat intake and severe obesity (BMI ≥ 99th percentile) was determined using multivariable logistic regression. Data were available for 145 children, of whom 17% were severely obese. Severely obese children had a lower mean intake of milk fat (5.3 g vs. 8.9 g) and fewer drank any milk (79% versus 95% for not severely obese children (p < 0.01)). Among the potential confounders assessed, maternal BMI and maternal marital status were associated with severe obesity and were included in a multivariate model. In the multivariate model, higher milk fat consumption was associated with lower odds of severe obesity (OR 0.88 CI 0.80-0.97). Higher milk fat consumption is associated with lower odds of severe obesity among Latino preschoolers. These results call into question recommendations that promote consumption of lower fat milk.

4.
Clin Pediatr (Phila) ; 56(7): 659-666, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28503997

RESUMEN

The development of children's mealtime television (TV) habits has not been well studied. We assessed whether mealtime TV habits established in infancy will persist into early childhood. We analyzed data collected through parent surveys at birth and at 6-month intervals from a randomized controlled trial. We used t-tests, χ2 tests, and a multivariable logistic regression to determine if family characteristics were associated with mealtime TV. A McNemar test was used to assess whether mealtime TV exposure changed over time. College-educated fathers and families with an annual income >$50 000 were associated with less-frequent TV exposure during children's mealtimes. It was found that 84% of children retained their level of exposure to TV during mealtimes from the first 24 months through 48 months of life. Clinicians should counsel families about mealtime TV use within the first 2 years of life because these habits seem to develop early and persist into at least early childhood.


Asunto(s)
Conducta Infantil/psicología , Conducta Alimentaria/psicología , Hábitos , Televisión/estadística & datos numéricos , Preescolar , Femenino , Humanos , Lactante , Masculino , Padres/psicología , Encuestas y Cuestionarios
5.
Paediatr Perinat Epidemiol ; 21 Suppl 3: 23-8, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17935572

RESUMEN

The hygiene hypothesis suggests that the absence of infectious exposure at a critical point in immune system development leads to a greater risk for the later development of atopic disease. As a result, it may be possible to devise strategies that can block the onset of atopic diseases such as asthma. This paper outlines the rationale, background and design for the Trial of Infant Probiotic Supplementation study, which is designed to test the effectiveness of a daily infant probiotic supplement in the first 6 months of life in preventing the development of early markers of asthma.


Asunto(s)
Asma/prevención & control , Dermatitis Atópica/prevención & control , Lactobacillus , Probióticos/uso terapéutico , Preescolar , Femenino , Humanos , Hipersensibilidad/prevención & control , Lactante , Recién Nacido , Masculino , Embarazo , Probióticos/administración & dosificación , Resultado del Tratamiento
6.
Am J Gastroenterol ; 101(10): 2247-53, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17032189

RESUMEN

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of metabolic syndrome. Insulin resistance (IR) is a key component of metabolic syndrome. The aim was to determine the dietary composition, physical activity, and histologic severity between NAFLD patients with and without metabolic syndrome. METHODS: Ninety-one patients with NAFLD completed the Block Food Frequency Questionnaire and the Paffenbarger Physical Activity Questionnaire. IR was assessed by the homeostasis model assessment (HOMA) index. Metabolic syndrome was defined by the ATP III clinical definition. Nonalcoholic steatohepatitis (NASH) Clinical Network Scoring System was used to determine the histologic severity of NAFLD. RESULTS: Thirty-one patients (34%) had metabolic syndrome. Patients with metabolic syndrome had a higher HOMA index (7.66 vs 4.45, p = 0.04), and consumed more carbohydrates (51%vs 45%, p = 0.03) and less fat (34%vs 40%, p = 0.01) compared with those without metabolic syndrome; total daily calorie, protein consumption, and physical activity were similar between the two groups. Patients with metabolic syndrome had higher scores for steatosis (2.0 +/- 0.8 vs 1.37 +/- 1, p = 0.02), NASH activity (4.13 +/- 1.4 vs 3.13 +/- 1.7, p = 0.004), and global NASH score (5.9 +/- 1.7 vs 4.4 +/- 2.3, p = 0.0006) compared with those without metabolic syndrome. When controlled for other factors including dietary composition and physical activity, the presence of metabolic syndrome was a significant risk factor for global NASH severity in addition to HOMA index and female gender. CONCLUSION: Metabolic syndrome in patients with NAFLD is associated with a diet containing more carbohydrate and less fat and greater histologic severity. The role of a carbohydrate-restricted diet in decreasing the risk for metabolic syndrome and histologic severity should be assessed in patients with NAFLD.


Asunto(s)
Dieta , Ejercicio Físico , Hígado Graso/complicaciones , Hígado Graso/patología , Síndrome Metabólico/complicaciones , Adulto , Anciano , Consumo de Bebidas Alcohólicas , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Síndrome Metabólico/patología , Síndrome Metabólico/psicología , Persona de Mediana Edad , Estudios Prospectivos , Índice de Severidad de la Enfermedad
7.
Clin Pediatr (Phila) ; 45(5): 405-10, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16891272

RESUMEN

Probiotics are live microorganisms that help stabilize and balance intestinal microflora. Although these organisms are ubiquitous and have been used in the production of foods, probiotics have been used more frequently for therapeutic purposes, including the treatment and prevention of pediatric diseases. This article reviews the proposed mechanisms of the beneficial effects of probiotics, potential uses of these organisms in pediatric care, and promising future directions for their application.


Asunto(s)
Probióticos/uso terapéutico , Bifidobacterium/inmunología , Niño , Medicina Basada en la Evidencia , Enfermedades Urogenitales Femeninas/prevención & control , Enfermedades Gastrointestinales/prevención & control , Enfermedades Gastrointestinales/terapia , Humanos , Lactobacillus/inmunología , Enfermedades Urogenitales Masculinas , Neoplasias/prevención & control , Pediatría , Probióticos/efectos adversos
8.
Appetite ; 45(2): 177-81, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15951056

RESUMEN

We tested the hypothesis that exercise energy expenditure (EEE) will elicit reflex metabolic compensations but no increases in hunger. Exercise expended 800 kcal once when fasted and at another time in a post-prandial state. During fasting exercise, pre-meal ratings of hunger were unaffected by EEE, but plasma concentrations of ghrelin, growth hormone and free fatty acids were higher than in the absence of EEE. We propose that the perception of hunger is based on the vagal, lateral hypothalamic and cortical projections of oral and gastro-intestinal (GI) stimuli and that EEE triggers neuroendocrine compensations and influences hunger indirectly by affecting GI functions.


Asunto(s)
Metabolismo Energético , Ejercicio Físico/fisiología , Hambre , Ácidos Grasos/sangre , Femenino , Ghrelina , Hormona de Crecimiento Humana/sangre , Humanos , Persona de Mediana Edad , Sistemas Neurosecretores/fisiología , Hormonas Peptídicas/sangre , Periodo Posprandial
9.
Am J Gastroenterol ; 100(5): 1072-81, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15842581

RESUMEN

BACKGROUND AND AIM: In individuals with biopsy-proven non-alcoholic steatohepatitis (NASH), short-term weight loss has been shown to improve biochemical abnormalities; however, its effect on liver histology is largely unknown. The aim of the article is to determine if dietary intervention is effective in improving histological features of steatohepatitis in patients with biopsy-proven NASH. METHODS: Twenty-three patients (11M/12F) with BMI >25 kg/m(2) and biopsy-proven NASH received standardized nutritional counseling aimed at reducing insulin resistance (IR) and weight. Blood tests were checked at baseline and every 1-4 months, and liver biopsy was repeated at month 12. IR was assessed by the homeostasis model assessment (HOMA). Liver biopsies were scored according to modified Brunt criteria for NASH. "Histologic response" was defined as a reduction in total NASH score of >/=2 points with at least one point being in the non-steatosis component. RESULTS: Sixteen patients (8M/8F) completed 12 months of dietary intervention, and 15 underwent repeat liver biopsies. At month 12, mean weight decreased from 98.3 to 95.4 kg. Mean waist circumference, visceral fat, fasting glucose, IR, triglycerides, AST, ALT, and histologic score were all reduced but the difference was not significant. Nine patients had a histologic response, six had stable scores, and none had a worsened score. Compared to patients with unchanged histologic scores, patients with improved scores had significantly greater reduction in weight, waist circumference, AST, ALT, steatosis grade, and total NASH score. CONCLUSION: Among patients who successfully completed 1 yr of intense dietary intervention, nine of 15 patients with NASH displayed histologic improvement. This pilot study suggests that dietary intervention can be effective in improving histology in patients with biopsy-proven NASH.


Asunto(s)
Consejo , Hígado Graso/dietoterapia , Ciencias de la Nutrición/educación , Tejido Adiposo/patología , Adulto , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Biopsia , Glucemia/análisis , Composición Corporal/fisiología , Índice de Masa Corporal , Hígado Graso/sangre , Hígado Graso/patología , Femenino , Estudios de Seguimiento , Hepatitis/sangre , Hepatitis/dietoterapia , Hepatitis/patología , Homeostasis/fisiología , Humanos , Resistencia a la Insulina/fisiología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Triglicéridos/sangre , Pérdida de Peso/fisiología
10.
Br J Nutr ; 90(3): 581-7, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-13129464

RESUMEN

Fructo-oligosaccharides (FOS) may have potential benefits, since they exhibit many soluble dietary fibre-like properties. Foods currently available for weaning infants are generally low in fibre content and lack these potential benefits. Data documenting tolerance of FOS in weaning foods are greatly lacking. Our present objective was to evaluate the tolerance and gastrointestinal effects of FOS-supplemented infant cereal used as a daily addition to the diet of healthy infants. Healthy infants were randomly assigned to receive either 0.75 g FOS per serving of cereal or placebo for 28 d. The primary outcome of interest was gastrointestinal tolerance, which was assessed by daily parental reporting of functional variables for 28 d, including stool patterns and signs and symptoms of gastrointestinal tolerance. Secondary outcomes were also measured including: cereal intake (g cereal and g FOS/d), stool pH, changes in anthropometric measurements and adverse events. The study population included a total of fifty-six infants, age range 16.2-46.2 weeks with a mean age of 32.5 (sd 8.9) weeks; twenty-nine infants were randomized to the control group (age 31.8 (sd 9.0) weeks) and twenty-seven to the FOS-supplemented group (34.7 (sd 8.9) weeks). Average daily total intake per infant and average intake per serving were similar in both groups. Average FOS consumption was 0.74 (sd 0.39) g/d and as high as 3.00 g/d. Stool consistency was less likely to be described as 'hard', and more likely to be described as 'soft' or 'loose', in the FOS v. control group. The mean number of stools per infant was 1.99 (sd 0.62) per d in the FOS-supplemented group compared with 1.58 (sd 0.66) in the control group (P=0.02). There were no differences between the groups in reporting for crying, spitting-up or colic. No differences were found for stool pH. FOS-supplements added to cereal were well tolerated in doses of up to 3.00 g/d. FOS consumption led to more regular and softer stools, without diarrhoea, as well as less-reported frequency of symptoms associated with constipation such as hard stools or skipped days without stool. The present study is one of few studies documenting tolerance to increased fibre intake in the form of FOS as part of a weaning food.


Asunto(s)
Fibras de la Dieta/administración & dosificación , Alimentos Infantiles , Fenómenos Fisiológicos Nutricionales del Lactante , Oligosacáridos/administración & dosificación , Distribución de Chi-Cuadrado , Método Doble Ciego , Ingestión de Alimentos , Grano Comestible , Heces , Frutas , Humanos , Concentración de Iones de Hidrógeno , Lactante , Aceptación de la Atención de Salud , Destete
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA